Harnessing the synergy of contact brachytherapy and immune checkpoint inhibitors in advanced melanoma: first reported case series
Single-fraction contact HDR-BT in combination with CHI appears to be a safe and effective palliative strategy for metastatic melanoma, offering fast local control, minimal toxicity, and potential systemic immune benefits.
Institutions
- Poznan University of Medical Sciences (PL)
- Greater Poland Cancer Center (PL)
Publication Details
- Journal
- Reports of Practical Oncology & Radiotherapy
- Published
- 2025-10-31
- DOI
- https://doi.org/10.5603/rpor.108661
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca
- GlaxoSmithKline
- Astellas Pharma